Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 350

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 350
---
 — |
| Warrants                             |     |               | 12,129,635 |     |      | 10,131,268 |
| Total                                |     |               | 18,635,819 |     |      | 36,232,332 |

**Note 6-Other current assets**

Other current assets consist of the following as of June 30, 2025, and December 31, 2024:

|                               |     |   | June 30,2025 |     |   | December 31,2024 |
|:------------------------------|:----|:--|-------------:|:----|:--|-----------------:|
| Employee Retention Tax Credit |     | $ |      214,699 |     | $ |          214,699 |
| NIH Grant Receivable          |     |   |      194,670 |     |   |          222,702 |
| Clinical trial deposit        |     |   |      204,955 |     |   |          204,955 |
| Other current assets          |     |   |      414,764 |     |   |          316,352 |
|                               |     | $ |    1,029,088 |     | $ |          958,708 |

F-105

**Note 7-Propertyand equipment, net**

Property and equipment, net consists of the following as of June 30, 2025, and December 31, 2024:

|                                                |     |   | June 30,2025 |   |     |   | December 31,2024 |   |
|:-----------------------------------------------|:----|:--|-------------:|:--|:----|:--|-----------------:|:--|
| Furniture and fixtures                         |     | $ |      170,607 |   |     | $ |          170,607 |   |
| Leasehold improvements                         |     |   |      544,629 |   |     |   |          544,629 |   |
| Machinery and office equipment                 |     |   |    1,471,417 |   |     |   |        1,423,183 |   |
| Software                                       |     |   |       72,394 |   |     |   |           72,394 |   |
|                                                |     |   |    2,259,047 |   |